Attendance at the Biotech CEO Sisterhoodโ€™s annual photo of women leaders and allies in Union Square doubled this year.
GSK is staking billions on a new way to protect people from lifeโ€‘threatening food allergies, agreeing to buy RAPT ...
Global drugmakers are ramping up U.S. manufacturing and stockpiling inventory as the Trump administration considers a 100% ...
GSK said Tuesday that it made a deal to pay RAPT shareholders $58 per share, with $1.9 billion upfront investment in cash. The acquisition is expected to close in the first quarter of 2026 with an ...
Though specific data for bepirovirsen remain under wraps, GSK plans to file for approval in the first quarter of 2026.
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The deal would give the South ...
GSK is officially cutting ties with Ideaya Biosciences, handing back two clinical programs as part of the termination of a 2020 licensing agreement. The breakup was initiated by GSK on Dec. 4, Ideaya ...
GSK has paid $50 million upfront to partner with LTZ Therapeutics on myeloid cell engagers, expanding its cancer pipeline to cover a modality that has attracted Eli Lilly, Novartis, Pfizer and Sanofi.
· These critical projects aim to enhance understanding and advance solutions to the urgent public health threat of AMR and drug-resistant infections GSK and the Fleming Initiative today announced six ...
Nov 8 (Reuters) - Diageo (DGE.L), opens new tab, the world's top spirits maker, has considered external candidates for its chief executive role including outgoing GSK (GSK.L), opens new tab CEO Emma ...
GSK finally has the long-awaited FDA approval it sought for blood cancer drug Blenrep. Three years after the pharmaceutical giant pulled the multiple myeloma therapy from the market, the FDA approved ...
This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...